Skye Bioscience Files 2024 10-K
Ticker: SKYE · Form: 10-K · Filed: Mar 20, 2025 · CIK: 1516551
Sentiment: neutral
Topics: 10-K, pharmaceutical, annual-report
TL;DR
Skye Bioscience filed its 2024 10-K. Check financials.
AI Summary
Skye Bioscience, Inc. filed its 2024 10-K on March 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Emerald Bioscience, Inc. and Nemus Bioscience, Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector. Its principal business address is in San Diego, California.
Why It Matters
This filing provides a comprehensive overview of Skye Bioscience's financial performance and business operations for the fiscal year 2024, crucial for investors assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Skye Bioscience faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- Skye Bioscience, Inc. (company) — Filer
- Emerald Bioscience, Inc. (company) — Former Company Name
- Nemus Bioscience, Inc. (company) — Former Company Name
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-20 (date) — Filing Date
- San Diego, CA (location) — Business Address
FAQ
What was Skye Bioscience's fiscal year end?
Skye Bioscience's fiscal year end was December 31, 2024.
When was the 10-K filing submitted?
The 10-K filing was submitted on March 20, 2025.
What is Skye Bioscience's Standard Industrial Classification (SIC) code?
Skye Bioscience's SIC code is 2834, Pharmaceutical Preparations.
In which state is Skye Bioscience incorporated?
Skye Bioscience is incorporated in Nevada (NV).
What are some of Skye Bioscience's former company names?
Skye Bioscience was formerly known as Emerald Bioscience, Inc. and Nemus Bioscience, Inc.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding Skye Bioscience, Inc. (SKYE).